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Abstract: 5-Phenyl-1,3-dihydro-2H-1,4-benzodiaze-
pin-2-ones react under palladium- and visible light
photoredox catalysis, in refluxing methanol, with
aryldiazonium salts to afford the respective 5-(2-
arylphenyl) analogues. With 2- or 4-fluorobenzene-
diazonium derivatives, both fluoroaryl- and me-
thoxyaryl- products were obtained, the latter result-
ing from a SNAr on the fluorobenzenediazonium
salt (“nuisance effect”). A computational DFT
analysis of the palladium-catalysed and the palla-
dium/ruthenium-photocalysed mechanism for the
functionalization of benzodiazepines indicated that,
in the presence of the photocatalyst, the reaction
proceeds via a low-energy SET pathway avoiding
the high-energy oxidative addition step in the
palladium-only catalysed reaction pathway.
Keywords: CH activation; benzodiazepine; photo-
catalysis; palladacycle; DFT
1 Introduction
There is a growing impetus for atom economical
routes to high value end products employing late stage
functionalization (LSF) processes.[1] These are partic-
ularly desirable in medicinal chemistry since they
increase diversity and chemical space and enable rapid
SAR (structure activity relationship) and ADME-Tox
(Absorption, distribution, metabolism, elimination-
toxicity) feedback that is key to costly, high attrition,
drug development. Late stage CH activation is a
powerful tool in generating novel compounds for
biological evaluation.[2] We recently described a palla-
dium-catalyzed ortho-arylation of benzodiazepines
employing iodonium salts in acetic acid under micro-
wave irradiation.[3] The harsh conditions, relatively
high commercial cost, and multistep synthesis of
iodonium salts[4] (ArIAr’+), coupled with a poor atom
economy (ArI is a byproduct) prompted us to
consider a visible-light photocatalyzed Pd-mediated
protocol involving diazonium salts.[5]
2 Results and Discussion
Our initial reaction trials were performed on the
benzodiazepine 1a, using the 2-fluoro-benzenediazo-
nium salt 2a under reflux (external oil bath temper-
ature set at 70 8C). To our surprise, in addition to the
expected product 3a, we were able to isolate the ether
product 4a. However, reaction of the 3-isomer 2b led
exclusively to the fluorobiaryl derivative 3b, whereas
the 4-isomer 2c afforded a mixture of fluorobiaryl 3c
and methoxy product 4c (Scheme 1). Repeating the
reaction in ethanol led to the ethyl ether 4d whose x-
ray structure is displayed (Scheme 1).
Characterization of 4c was enabled by determina-
tion of its solid state x-ray structure[6] (Scheme 1) and
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by its unequivocal synthesis starting from 4-methox-
ybenzenediazonium tetrafluoroborate 2d (Table 1)
where we found slightly better yields under reflux
(Entry 1 vs. 2) compared to either ambient temper-
ature or to the absence of photocatalyst (Entry 5).
Moreover, a palladium catalyst was essential (Entry 4)
for achieving a good yield. Microwave-mediated
chemistry, in the absence of light and photocatalyst,
gave little conversion of product.
To explain the formation of the ether products we
propose a competing SNAr, termed “nuisance effect,”
which has historically been observed for halogen-
substituted benzenediazonium salts, given the strong
electron withdrawing effects of the diazo group,
notably operating on the 2- and 4-substituted iso-
mers.[7] Indeed, simple alcoholysis of compound 2c
was achieved in the appropriate alcohol solvent at
70 8C (Scheme 2).
The CH activation reaction was also applied to
aryldiazoniums incapable of undergoing such a F-
substitution and, hence derivatives 4e–4 i‘ were syn-
thesized in good to excellent yields (Scheme 3) and
the structure of 4h was determined by x-ray crystallog-
raphy. Indeed, yields tend to be either similar or
higher than those reported for the corresponding
reactions involving iodonium salts, e. g. 4e (60% vs.
56%), 4 f (54% vs. 35%), 4g (71% vs. 55%) and 4 i
(64% vs. 63%).
In the synthesis of 4 i, relatively large amounts of
the diarylated adduct 4 i‘ were also observed. Such di-
arylations were previously reported by us.[3b]
The current and previous library of benzodiaze-
pines (Scheme 1) was tested for GABA binding.[8]
Scheme 1. Benzodiazepine library synthesis.
Table 1. Synthesis of an anisole derivative.
Entry Lamps
26 W
Pd(OAc)2
(mol%)
Ru(bpy)3
Cl2.
6H2O
(mol%)
Temp.
(oC)
Conv. LC/MS
(%)
1 Yes 10 2.5 rt 52
2 Yes 10 2.5 Reflux[a] 61
3 No 10 2.5 Reflux[a] 35
4 Yes 0 2.5 Reflux[a] 0
5 Yes 10 0 Reflux[a] 57
6 No 10 0 [b] 20
[a] External oil bath temperature; 70 8C,
[b] microwave (MW), 125 8C, 1 h.
Scheme 2. “Nuisance effect” on diazonium salts.
Scheme 3. Other arylated benzodiazepines.
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None of the current benzodiazepines displayed any
appreciable biological activity although 7-chloro-ben-
zodiazepines, as expected, had reasonable activity,
although were ca. 7–10 fold less active than nordaze-
pam and diazepam controls (Entries 1 and 2 respec-
tively, Table 2) and were not pursued any further.
Sanford et al. proposed a possible mechanism to
explain their Pd/Ru photocatalysed CH arylation.[5a]
Here we present a computational study of a Pd-
catalysed and a Sanford-derived Pd/Ru photocalysed
mechanism for the functionalization of 1a to 4g
(Scheme 4) to rationalise the increased yield in the
presence of light and a Ru photocatalyst.
The detailed mechanism is shown in Scheme 5 and
the reaction profile (relative to the reactants) in
Figure 1. The reaction mechanism, with and without
the Ru(II)-photocatalyst, essentially follows the same
path except that the oxidative addition step in the
presence of just the Pd(II)-catalyst (path shown in
green, Scheme 5 and Figure 1), is replaced by a single-
electron-transfer (SET) process when the Ru(II)-
photocatalyst is added (shown in red, Scheme 5 and
Figure 1).
The initial step of the catalysed mechanism
involves the coordination to Pd(OAc)2 by a N atom
on the un-functionalised benzodiazepine to provide
Int1, followed by the formation of an agostic complex
Int2 prior to CH activation. The atomic distance
between Pd and the agostic H in Int2 is 1.903 A˚, which
is in good agreement with similar agostic interactions
in the literature: PdH=1.91 A˚[9] and RhH
(1.95 A˚).[10] The barrier to CH bond activation is
41.4 kJmol1, and involves H migration from C to O
via a six-membered ring (TS2-3). Prior to coordination
with the p-nitrobenzenediazonium (Ar-N2
+) the com-
plex undergoes an isomerisation step (TS3-4), which
involves a change in the C1PdO3 angle from 132.0
to 172.0 degrees with an energy barrier of
27.8 kJmol1 to form Int4.
In the absence of the photocatalyst, Ar-N2
+
interacts with the Pd(II) complex and follows an
oxidation addition (OA) pathway, (highlighted in
green, Scheme 5 and Figure 1). The oxidative addition
via TS5-6(OA) has an energy barrier of 127.1 kJmol1
and involves the formation of an ArPd(IV) complex.
The N2 is then eliminated leading to Int7.
When the Ru(II)-photocatalyst is present, the
nitrobenzene radical (Ar*) is generated from Ar-N2
+
(via oxidative quenching of Ar-N2
+ by the photo-
excited [Ru(bpy)3]
2+ complex to form [Ru(bpy)3]
3+)[11]
and follows a single-electron-transfer (SET) pathway,
(in red, Scheme 5 and Figure 1). The square planar
geometry of the Pd(II) complex Int4 becomes a
Pd(III) distorted-octahedral structure when the Ar
binds to the Pd centre in Int5(SET); this is consistent
with the crystal structure of other Pd(III)-complexes
although we did not consider bimetallic species.[12] Int7
is formed directly from Int5(SET) by the transfer of
an electron to the [Ru(bpy)3]
3+ complex to recover
Table 2. GABA activity of library.
Entry Compound mean Ki (nM)/
SEM (nM) vs.
GABA.
1 51.622.0
2 41.414.9
3 373.45110.5
4 421.5486.1
5 303.2560.7
6 689.56480.3
Scheme 4. The formation reaction of 4g with (i) and without
(ii) the Ru photocatalyst, investigated using DFT.
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the photocatalyst. The Gibbs free energy barrier for
single electron transfer (SET) resulting in the forma-
tion of the Pd(IV) complex Int7 was calculated to be
2.5 kJmol1 using Marcus and Save´ant theory.[13] The
details of this calculation are provided in the Compu-
tational Method section. This barrier is very small but
similar to literature values that range from 0.4–
15.1 kJmol1.[14]
Both mechanisms (OA and SET) result in the
same Pd(IV) structure for Int7. At this stage reductive
elimination occurs via TS7-8 with a barrier of
43.2 kJmol1. This step involves the formation of a
CC bond to facilitate the functionalization of the
benzodiazepine and the oxidation state of the Pd-
center changes from Pd(IV) to Pd(II) (Int7!Int8).
The geometry Int8, involves an h2(C=C) interaction
with Pd. A similar interaction was observed by
Ariafard et al.[15] and Canty et al.[16] in their DFT
calculations and in a palladium complex crystal
structure.[17]
It is clear from Figure 1 that, in the presence of the
Pd-catalyst, the oxidative addition step is rate deter-
mining with a considerable energy barrier. However,
in the presence of both the Pd(II)-catalyst and the
Ru(II)-photocatalyst this OA step, and hence large
energy barrier, is avoided as the reaction proceeds via
a very low-energy single-electron-transfer process.
This provides a rationale for the increased yield in the
presence of a photocatalyst.
Conclusion
The CH activation of benzodiazepines with 2- or 4-
fluorobenzene diazonium salts under Pd catalysis with
a Ru photocatalyst, in alcohol solvent, under reflux,
leads to a mixture of both fluoroaryl and alkoxyaryl
products. Reaction temperature is a key factor in
determining the ratio of expected vs. “nuisance effect”
(SNAr) products. At ambient temperature trace
amounts of the SNAr product are detected whereas
significant amounts can be obtained after prolonged
heating under reflux. This process can also be
extended to other aryl diazonium salts affording
ortho-arylated benzodiazepines. These were tested for
biological activity but were found to be significantly
less active than e.g. nordazepam and diazepam
controls. Density functional theory (DFT) has been
used to provide a detailed mechanistic understanding
of the functionalization of the benzodiazepines and to
offer an explanation for the increased yield in the
presence of a Ru(II)-photocatalyst. The Pd/Ru cata-
lytic cycle follows the mechanism proposed by
Sandford et al.[5a] The increased yield in the visible-
light photocatalysed Pd-mediated protocol is attrib-
uted to the transformation step leading to the
formation of the Pd(IV) complex. In the presence of
the photocatalyst the reaction proceeds via a low-
energy SET pathway and avoids the high-energy
oxidative addition step in the Pd-only catalysed
reaction pathway.
Current studies are aiming to extend the arylation/
nuisance effect chemistry to a wider scope of priv-
ileged structures with different nucleophiles for appli-
cation in medicinal chemistry library generation and
will be reported in due course.
Scheme 5. The reaction mechanism for the functionalization
of benzodiazepine. From Int4 to Int7 the transformation
follows the green path in the presence of the Pd catalyst and
the red path in the presence of the Pd/Ru catalysts. Both
paths were considered.
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Experimental Section
General Information
All reactions were conducted under an inert atmosphere
unless specified otherwise. All commercially purchased
materials and solvents were used without further purification
unless specified otherwise.
NMR spectra were recorded on a Varian V NMRS 500 (1H:
500 MHz, 13C: 126 MHz) spectrometer and prepared in
deuterated solvents such as CDCl3 and DMSO-d6.
1H and 13C
chemical shifts were recorded in parts per million (ppm).
Multiplicity of 1H-NMR peaks are indicated by s – singlet, d
– doublet, dd – doublets of doublets, t – triplet, pt – pseudo
triplet, q – quartet, m – multiplet and coupling constants are
given in Hertz (Hz).
Electrospray ionisation – high resolution mass spectra (ESI-
HRMS) were obtained using a Bruker Daltonics Apex III
where Apollo ESI was used as the ESI source. All analyses
were conducted by Dr A. K. Abdul-Sada at Sussex. The
molecular ion peaks [M]+ were recorded as mass to charge
(m/z) ratio.
LC–MS spectra were acquired using a Shimadzu LC–MS
2020, on a Gemini 5 mm C18 110 A˚ column and percentage
purities were run over 30 minutes in water/acetonitrile with
0.1% formic acid (5 min at 5%, 5%–95% over 20 min, 5 min
at 95%) with the UV detector at 254 nm. Purifications were
performed by flash chromatography on silica gel columns or
C18 columns using a Combi flash RF 75 PSI, ISCO unit. The
following CCDC deposition numbers have been obtained, in
parentheses; for 4c (1518056), 4d (1551609) and 4h
(1551610).
4-Methoxybenzenediazonium Tetrafluoroborate (2d)
A stirred suspension of 4-fluorobenzenediazonium tetrafluor-
oborate (0.10 g, 0.48 mmol) in methanol (2 mL) was heated
at 70 8C by using an external oil bath for 1 hour. The reaction
was allowed to cool to ambient temperature and concen-
trated under reduced pressure. The residue was precipitated
by the addition of diethyl ether and collected by filtration,
affording 2d as a white solid (0.090 g, 85%). The spectral
data were concurrent with those reported.[18]
4-Ethoxybenzenediazonium Tetrafluoroborate (2e)
The reaction was conducted by the same procedure as for 2d
but ethanol (2 mL) was used instead of methanol and heated
at 70 8C for 1 hour. 2e was obtained as a white solid (0.071 g,
63%). The spectral data were concurrent with those
reported.[19]
2-Methoxybenzenediazonium Tetrafluoroborate (2 f)
The reaction was conducted by the same procedure as for 2d
but 2-fluorobenzenediazonium tetrafluoroborate (0.10,
0.48 mmol) was used instead. 2f was obtained as a white
solid (0.073 g, 72%). The spectral data were concurrent with
those reported.
Figure 1. The reaction energy profile for the formation of 4g from 1a, with (red path) and without (green path) a
photocatalyst. Steps common to both mechanisms are shown in blue. [Ru2+] and [Ru3+] represent [Ru(bpy)3]
2+ and
[Ru(bpy)3]
3+, respectively.
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5-(2’-Fluorobiphenyl-2-yl)-1,3-dihydro-2H-1,4-benzo-
diazepin-2-one (3a);
5-(2’-methoxybiphenyl-2-yl)-1,3-dihydro-2H-1,4-ben-
zodiazepin-2-one (4a)
5-Phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one (0.070 g,
0.3 mmol), 2-fluorobenzenediazonium tetrafluoroborate
(0.25 g, 1.20 mmol) and palladium (II) acetate (0.0067 g,
0.03 mmol) were suspended in degassed, anhydrous meth-
anol (5 mL). Two fluorescent light bulbs (26 W) were placed
on either side of the reaction vessel and the reaction mixture
was heated at 70 8C by using an external oil bath for 4 hours.
The reaction was allowed to cool to ambient temperature,
diluted with ethyl acetate (50 mL), washed with water
(20 mL) and aqueous sodium sulphite (10%, 35 mL 32). The
layers were separated and the combined aqueous layers were
extracted with ethyl acetate (50 mL). Thereafter the com-
bined organic layer was washed with brine (50 mL), dried
(MgSO4) and concentrated under reduced pressure. The
resulting crude material was purified by reversed phase
chromatography (water/acetonitrile with 0.1% formic acid,
5 min at 0%, 30%–90%). Starting material 1a was recovered
(0.014 g, 0.06 mmol). Two products were generated; 3a was
obtained as a white solid (0.022 g, 28%) and 4a was obtained
as a white solid (0.030 g, 37%). 3a: The spectral data were
concurrent with those reported.3 4a: 1H-NMR (500 MHz)
CDCl3: d=7.98 (s, NH, 1H), 7.68 (d,
3JHH=7.0 Hz, ArH,
1H), 7.52–7.42 (m, ArH, 2H), 7.28 (d, 3JHH=8.0 Hz, ArH,
1H), 7.19–7.12 (m, ArH, 1H), 7.06–6.98 (m, ArH, 2H), 6.90–
6.83 (m, ArH, 1H), 6.80 (d, 3JHH=7.5 Hz, ArH, 1H), 6.69–
6.60 (m, ArH, 2H), 6.52 (d, 3JHH=8.0 Hz, ArH, 1H), 4.22 (s,
COCH2, 2H), 3.51 (s, O-CH3, 3H).
13C-NMR (126 MHz)
CDCl3: d=173.1(C=O), 171.1 (C=N), 156.1 (ArC), 140.8
(ArC), 139.0 (ArC), 137.4 (ArC), 131.3 (ArC), 131.5 (ArC),
131.4 (ArC), 131.1 (ArC), 130.3 (ArC), 129.8 (ArC), 129.6
(ArC), 129.3 (ArC), 128.9 (ArC), 127.7 (ArC), 123.3 (ArC),
120.3 (ArC), 120.2 (ArC), 110.0 (ArC), 56.7 (COCH2), 55.3
(O-CH3). HRMS-ESI (m/z) calculated for C22H18FN2O2 [+
H] + : 343.1441, found: 343.1446. LCMS purity (UV)=96%,
tR 10.63 min.
5-(3’-Fluorobiphenyl-2-yl)-1,3-dihydro-2H-1,4-benzo-
diazepin-2-one (3b)
The reaction was conducted on a 0.20 mmol scale by the
same procedure as for 3a/4a but 3-fluorobenzenediazonium
tetrafluoroborate (0.17 g, 0.8 mmol) was used instead of 2-
fluorobenzenediazonium tetrafluoroborate. Starting materi-
al, 1a was recovered (0.010 g, 0.042 mmol) and 3b was
obtained as a white solid (0.040 g, 77%). The spectral data
were concurrent with those reported.
5-(4’-Fluorobiphenyl-2-yl)-1,3-dihydro-2H-1,4-benzo-
diazepin-2-one (3c);
5-(4’-Methoxybiphenyl-2-yl)-1,3-dihydro-2H-1,4-ben-
zodiazepin-2-one (4c)
This reaction was conducted on a 0.42 mmol scale by the
same procedure as 3a/4a and 4-fluorobenzenediazonium
tetrafluoroborate (0.35 g, 1.67 mmol) was used instead of 2-
fluorobenzenediazonium tetrafluoroborate. Starting materi-
al, 1a was recovered (0.015 g, 0.06 mmol) and the reaction
generated two products; 3c was obtained as a white solid
(0.053 g, 45%) and 4c was obtained as a white solid (0.038 g,
32%). 3c: 1H-NMR (500 MHz) DMSO-d6: d=10.39 (s, ArH,
1H), 7.60–7.55 (m, 1H), 7.55–7.52 (m, ArH, 1H), 7.50 (d,
3JHH=7.5, Hz, ArH, 1H), 7.33–7.30 (m, ArH, 1H), 7.21–7.17
(m, ArH, 1H), 6.92–6.86 (m, ArH, 4H), 6.83–6.77 (m, ArH,
2H), 6.69 (d, 3JHH=8.0 Hz, 1H), 4.03 (s, COCH2, 2H).
13C-NMR (126 MHz) DMSO-D6: d=172.1 (C=O), 169.7 (C=
N), 161.5 (d, 1JFC=244.0 Hz, ArC,), 140.4 (ArC), 139.8
(ArC), 139.2 (ArC), 136.9 (ArC), 131.5 (ArC), 130.4 (A rC),
130.5 (d, 3JFC=7.5 Hz, 23 ArC), 130.2 (ArC), 130.1 (ArC),
129.3 (ArC), 128.3 (ArC), 127.8 (ArC), 122.7 (ArC), 120.7
(ArC), 114.9 (d, 2JFC=22.0 Hz, 2 x ArC), 57.3 (COCH2).
HRMS-ESI (m/z) calculated for C21H15FN2O [+H]
+ :
331.1241, found: 331.1244. LCMS purity (UV)=92%, tR
11.16 min. 4c: The spectral data were concurrent with those
reported.
5-(4’-Ethoxybiphenyl-2-yl)-1,3-dihydro-2H-1,4-benzo-
diazepin-2-one (4d)
The same method as that of 3a/4a was used but ethanol
(5 mL) was used as the solvent instead of methanol. Starting
material, 1a, was recovered (0.020 g, 0.085 mmol). Two
products were generated, product 3c was obtained as a white
solid (0.043 g, 39%) and Product 4d was obtained as a white
solid (0.026 g, 22%). 4d: 1H-NMR (500 MHz) CDCl3: d=
8.20 (s, NH, 1H), 7.68 (d, 3JHH=7.5 Hz, ArH, 1H), 7.57–7.38
(m, ArH, 2H), 7.28 (d, 3JHH=7.5 Hz, ArH, 1H), 7.15 (pt,
3JHH=7.5 Hz, ArH, 1H), 6.91–6.81 (m, ArH, 4H), 6.69 (d,
3JHH=8.0 Hz, ArH, 1H), 6.60 (d,
3JHH=8.0 Hz, ArH, 2H),
4.29 (s, COCH2, 2H), 3.94 (q,
3JHH=7.0 Hz, O-CH2CH3, 2H),
1.36 (t, 3JHH=7.0 Hz, O-CH2CH3, 3H).
13C-NMR (126 MHz)
CDCl3: d=173.2 (C=O), 170.7(C=N), 157.8 (ArC), 141.7
(ArC), 139.5 (ArC), 137.3 (ArC), 133.2 (ArC), 131.1 (ArC),
130.1 (ArC), 129.9 (ArC), 129.7 (ArC), 129.8 (23 ArC),
129.5 (ArC), 129.1 (ArC), 128.1 (ArC), 126.9 (ArC), 123.1
(ArC), 113.8 (2 x ArC), 63.5 (O-CH2CH3), 56.5 (COCH2),
14.8 (O-CH2CH3). HRMS-ESI (m/z) calculated for C23H20N2
O2 [+Na]
+: 379.1417, found: 379.1419. LCMS purity (UV)=
87%, tR 10.89 min.
5-Phenyl-2-yl)-1,3-dihydro-2H-1,4-benzodiazepi-
n-2-one (4e)
The reaction was conducted by the same procedure as for
3a/4a but benzenediazonium tetrafluoroborate (0.23 g,
1.20 mmol) was used instead of 2-fluorobenzenediazonium
tetrafluoroborate. Starting material 1a was recovered
(0.016 g, 0.067 mmol) and 4e was obtained as a white solid
(0.043 g, 60%). All spectral data were concurrent with those
reported.
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5-(4’-Methoxybiphenyl-2-yl)-1,3-dihydro-2H-1,4-ben-
zodiazepin-2-one (4 f)
The reaction was conducted on a 0.32 mmol scale by the
same procedure as for 3a/4a but 4-methoxybenzenediazo-
nium tetrafluoroborate (0.28 g, 1.28 mmol) was used instead
of 2-fluorobenzenediazonium tetrafluoroborate. Starting ma-
terial, 1a was recovered (0.015 g, 0.063 mmol) and 4 f was
obtained as a white solid (0.048 g, 54%). All spectral data
were concurrent with those reported.
5-(4’-Nitrobiphenyl-2-yl)-1,3-dihydro-2H-1,4-benzo-
diazepin-2-one (4g)
The reaction was conducted on a 0.45 mmol scale by the
same procedure as for 3a/4a but 4-nitrobenzenediazonium
tetrafluoroborate (0.43 g, 1.80 mmol) was used instead.
Starting material, 1a was recovered (0.020 g, 0.085 mmol)
and 4g was obtained as a white solid (0.093 g, 71%). 1H-
NMR (500 MHz) CDCl3: d=8.78 (s, 1H), 7.94 (dd,
3JHH=8.5,
1.5 Hz, 2H), 7.78–7.72 (m, 1H), 7.60–7.52 (m, 2H), 7.34–7.28
(m, 1H), 7.22–7.13 (m, 3H), 6.90–6.83 (m, 2H), 6.72 (d, 3JHH=
8.0 Hz, 1H), 4.31 (s, COCH2, 2H). ).
13C-NMR (126 MHz)
CDCl3: d=172.1 (C=O), 170.6 (C=N), 147.4 (ArC), 146.6
(ArC), 139.7 (ArC), 139.6 (ArC), 137.5 (ArC), 131.7 (ArC),
130.4 (ArC), 129.9 (ArC), 129.8 (ArC), 129.6 (ArC), 129.5
(ArC x 2), 128.7 (ArC), 128.6 (ArC), 123.3 (ArC), 122.7
(ArC x 2), 120.1 (ArC), 56.5 (COCH2). HRMS-ESI (m/z)
calculated for C21H15N3O3 [+H]
+ : 358.1186, found: 358.1191.
Elemental Analysis: Calculated for C21H15N3O3 (%): C,
70.58, H, 4.23, N, 11.76, found: C, 70.41, H, 4.23, N, 11.60.
5-(4’-Bromobiphenyl-2-yl)-1,3-dihydro-2H-1,4-benzo-
diazepin-2-one (4h)
The reaction was conducted on a 0.25 mmol scale by the
same procedure as for 3a/4a but 4-bromobenzenediazonium
tetrafluoroborate (0.27 g, 1.0 mmol) was used instead. Start-
ing material, 1a was recovered (0.012 g, 0.051 mmol) and 4h
was obtained as a white solid (0.051 g, 65%). 1H-NMR
(500 MHz) DMSO-d6: d=10.44 (s, 1H), 7.56 (pt,
3JHH=
8.0 Hz, 2H), 7.54–7.48 (m, 1H), 7.34 (d, 3JHH=8.0 Hz, 1H),
7.28 (d, 3JHH=8.0 Hz, 2H), 7.23 (pt,
3JHH=7.5 Hz, 1H), 6.87
(dd, J=8.0, 5.9 Hz, 3H), 6.82 (pt, 3JHH=7.5 Hz, 1H), 6.73 (d,
3JHH=8.0 Hz, 1H), 4.05 (s, COCH2, 2H).
13C-NMR
(126 MHz) DMSO-d6: d=171.9 (C=O), 169.8 (C=N), 140.2
(ArC), 139.8 (ArC), 139.6 (ArC), 139.3 (ArC), 131.5 (ArC),
131.1 (ArC), 131.0 (ArC 32), 130.6 (ArC 32), 130.3 (ArC),
130.2 (ArC), 130.1 (ArC), 129.5 (ArC), 128.2 (ArC), 128.1
(ArC), 122.7 (ArC), 120.7 (ArC), 56.7 (COCH2). HRMS-ESI
(m/z) calculated for C21H15BrN2O [+H]
+ : 391.0441, found:
391.0449. LCMS purity (UV)=95%, tR 14.56 min.
5-(3’-Trifluoromethylbiphenyl-2-yl)-1,3-dihy-
dro-2H-1,4-benzodiazepin-2-one (4 i);
5-(3,3’-bistrifluoromethylbiphenyl-2,6-yl)-1,3-dihy-
dro-2H-1,4-benzodiazepin-2-one (4 i‘)
The reaction was conducted on a 0.39 mmol scale by the
same procedure as for 3a/4a but 3-trifluoromethylbenzene-
diazonium tetrafluoroborate (0.41 g, 1.56 mmol) was used
instead. 4 i was obtained as a brown solid (0.094 g, 64%) and
the bisarylated product, 4 i‘, was obtained as a brown solid
(0.061 g, 30%). 4 i: All spectral data were concurrent with
those reported. 4 i‘: 1H-NMR (500 MHz) DMSO-d6: d=10.01
(s, 1H), 7.66 (pt, 3JHH=7.5 Hz, 1H), 7.55 (d,
3JHH=8.0 Hz,
2H), 7.50 (d, 3JHH=7.5 Hz, 2H), 7.45 (pt,
3JHH=7.5 Hz, 2H),
7.41–7.36 (m, 4H), 7.22–7.18 (m, 1H), 6.96–6.89 (m, 2H), 6.75
(d, J=8.0 Hz, 1H), 3.65 (s, COCH2, 2H).
13C-NMR
(126 MHz) CDCl3: d=170.4 (C=O), 169.6 (C=N), 141.4
(ArC), 141.0 (ArC), 138.1 (ArC), 137.4 (ArC), 132.4 (ArC 3
2), 131.7 (ArC), 130.1 (q, 2JFC, 33 Hz, ArC 32), 129.8 (ArC
32), 129.4 (ArC 32), 129.3 (ArC 32), 128.7 (ArC), 128.2
(ArC 32), 125.8 (q, 3JFC, 3.5 Hz, ArC 32), 123.9 (q,
3JFC,
272.0 Hz ArC 32), 123.7 (q, 3JFC, 3.5 Hz, ArC x 2), 123.4
(ArC), 120.2 (ArC), 55.7 (COCH2). C29H18F6NO2 [+H]
+ :
525.1396, found: 525.1402. LCMS purity (UV)=98%, tR
22.50 min.
3 Computational Details
Density functional theory (DFT) calculations were
performed at the wB97XD/6-311+ +
G(2df,2p)[SDD]//PBE/6-31+G(d,p)[SDD] level of
theory, using the Gaussian09 program.[20] The Pople
basis sets were used on all atoms except Pd and Ru for
which the SDD relativistic effective core potentials
were used.[21] The PBE functional[22] was used for the
geometry optimisation and frequency analysis as it
combines good accuracy for Pd complexes with
computational speed.[23] The long-range corrected
hybrid functional wB97XD,[24] which includes empiri-
cal dispersion corrections, was used for energies to
ensure accurate energetics.[25] Methanol solvent energy
corrections were applied using the conductor-like
polarisable continuum model (CPCM).[26] Accordingly,
the Gibbs free energies presented in Figure 1 were
obtained by adding the thermal free energy correc-
tions obtained at the PBE/6-31+G(d,p)[SDD] level of
theory to the solvent-corrected electronic energies
obtained at the wB97XD/6-311+ +G(2df,2p)[SDD]
level of theory. All stationary states were verified as
minima or transition states by the absence or presence,
respectively, of a single imaginary vibrational fre-
quency. Eigenvector following was used to ensure
transition states connected the desired minima.
The Gibbs free energy barrier for single electron
transfer (SET), DG 6¼ET , was calculated using the following
equation from Marcus and Save´ant theory:[13b–d]
DG6¼ET ¼ DG 6¼0 1þ
DGr
4DG 6¼0
 2
ð1Þ
Here DGr is the reaction energy for the electron
transfer step and DG 6¼0 is the intrinsic barrier, which
can be calculated as:
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DG6¼0 ¼
l
4
ð2Þ
In Eq. (2), l is the reorganisation energy and
consists of the inner reorganisation energy of the
reactants, li, and the solvent reorganisation energy, lo.
For outer-sphere electron transfer as in the present
case, li is assumed to be zero (following literature
precedents[27]) thus l is equal to lo.
The reaction energy for the electron transfer step
DGr is calculated as the energy of the reaction:
Pd(III)-complex+ [Ru(bpy3)]
3+!Pd(IV)-complex+
[Ru(bpy3)]
2+ (i. e. Int5(SET) to Int7, Scheme 5). The
energy for this step is 83.4 kJmol1.
The reorganisation energy l ¼ lo is calculated
using the following equation:[27–28]
lo ¼
NAe
2
4pe0
1
eop
 1
es
 
1
2r1
þ 1
2r2
 1
R
 
ð3Þ
where NA is the Avogadro constant (6.0223
1023 mol1), e is the electronic charge (1.6023
1019 C), e0 is the vacuum permittivity (8.8543
1012 J1C2m1) and, eop and es are the optical and
static dielectric constant for solvent, respectively.
For methanol, eop is 1.76 and es is 32.613. r1, r2 and R
are the hard sphere radii of the donor, the acceptor,
and their sum. In this work, the hard sphere radii
approximation of [Ru(bpy)3]
3+ and the Pd(III)-
complex (Int5(SET)) were calculated using the
VOLUME keyword in Gaussian09. The calculated
[Ru(bpy)3]
3+ radius is 6.18 A˚ and the calculated
Pd(III)-complex radius is 6.47 A˚. Using these values
in Eq. (3) gives lo=59.1 kJmol
1, and hence DG 6¼0 =
14.8 kJmol1. Substituting these values for DG 6¼0 and
DGr in Eq. (1), provides a SET barrier, DG
6¼
ET=
2.5 kJmol1.
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